BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31354905)

  • 1. Bailcalin Protects against Diabetic Cardiomyopathy through Keap1/Nrf2/AMPK-Mediated Antioxidative and Lipid-Lowering Effects.
    Li R; Liu Y; Shan YG; Gao L; Wang F; Qiu CG
    Oxid Med Cell Longev; 2019; 2019():3206542. PubMed ID: 31354905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
    Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
    Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function.
    Sun Y; Zhou S; Guo H; Zhang J; Ma T; Zheng Y; Zhang Z; Cai L
    Metabolism; 2020 Jan; 102():154002. PubMed ID: 31706979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel compound AB38b attenuates oxidative stress and ECM protein accumulation in kidneys of diabetic mice through modulation of Keap1/Nrf2 signaling.
    Du L; Wang L; Wang B; Wang J; Hao M; Chen YB; Li XZ; Li Y; Jiang YF; Li CC; Yang H; Gu XK; Yin XX; Lu Q
    Acta Pharmacol Sin; 2020 Mar; 41(3):358-372. PubMed ID: 31645661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulforaphane prevents type 2 diabetes-induced nephropathy via AMPK-mediated activation of lipid metabolic pathways and Nrf2 antioxidative function.
    Li Z; Guo H; Li J; Ma T; Zhou S; Zhang Z; Miao L; Cai L
    Clin Sci (Lond); 2020 Sep; 134(18):2469-2487. PubMed ID: 32940670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CKIP-1 affects the polyubiquitination of Nrf2 and Keap1 via mediating Smurf1 to resist HG-induced renal fibrosis in GMCs and diabetic mice kidneys.
    Gong W; Chen Z; Zou Y; Zhang L; Huang J; Liu P; Huang H
    Free Radic Biol Med; 2018 Feb; 115():338-350. PubMed ID: 29248720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syringaresinol Protects against Type 1 Diabetic Cardiomyopathy by Alleviating Inflammation Responses, Cardiac Fibrosis, and Oxidative Stress.
    Li G; Yang L; Feng L; Yang J; Li Y; An J; Li D; Xu Y; Gao Y; Li J; Liu J; Yang L; Qi Z
    Mol Nutr Food Res; 2020 Sep; 64(18):e2000231. PubMed ID: 32729956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose radiation prevents type 1 diabetes-induced cardiomyopathy via activation of AKT mediated anti-apoptotic and anti-oxidant effects.
    Zhang F; Lin X; Yu L; Li W; Qian D; Cheng P; He L; Yang H; Zhang C
    J Cell Mol Med; 2016 Jul; 20(7):1352-66. PubMed ID: 26991817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats.
    Luo J; Yan D; Li S; Liu S; Zeng F; Cheung CW; Liu H; Irwin MG; Huang H; Xia Z
    J Cell Mol Med; 2020 Jan; 24(2):1760-1773. PubMed ID: 31856386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mulberry granules protect against diabetic cardiomyopathy through the AMPK/Nrf2 pathway.
    Liu Y; Zhao YB; Wang SW; Zhou Y; Tang ZS; Li F
    Int J Mol Med; 2017 Sep; 40(3):913-921. PubMed ID: 28677741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nrf2 prevents diabetic cardiomyopathy via antioxidant effect and normalization of glucose and lipid metabolism in the heart.
    Yang G; Zhang Q; Dong C; Hou G; Li J; Jiang X; Xin Y
    J Cell Physiol; 2024 Feb; 239(2):e31149. PubMed ID: 38308838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of Nrf2 signaling: A key molecular mechanism of Baicalin's neuroprotective action against diabetes-induced cognitive impairment.
    Zheng Y; Wang C; Liu W; Chen J; Sun Y; Chang D; Wang H; Xu W; Lu JJ; Zhou X; Huang M
    Biomed Pharmacother; 2024 May; 174():116579. PubMed ID: 38631145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pterostilbene Decreases Cardiac Oxidative Stress and Inflammation via Activation of AMPK/Nrf2/HO-1 Pathway in Fructose-Fed Diabetic Rats.
    Kosuru R; Kandula V; Rai U; Prakash S; Xia Z; Singh S
    Cardiovasc Drugs Ther; 2018 Apr; 32(2):147-163. PubMed ID: 29556862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diosmetin Protects against Cardiac Hypertrophy via p62/Keap1/Nrf2 Signaling Pathway.
    Guo Y; Li D; Cen XF; Qiu HL; Ma YL; Liu Y; Huang SH; Liu LB; Xu M; Tang QZ
    Oxid Med Cell Longev; 2022; 2022():8367997. PubMed ID: 35242278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SP600125 suppresses
    Zhang H; Liu X; Zhou S; Jia Y; Li Y; Song Y; Wang J; Wu H
    J Mol Endocrinol; 2018 Feb; 60(2):145-157. PubMed ID: 29273684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigallocatechin gallate upregulates NRF2 to prevent diabetic nephropathy via disabling KEAP1.
    Sun W; Liu X; Zhang H; Song Y; Li T; Liu X; Liu Y; Guo L; Wang F; Yang T; Guo W; Wu J; Jin H; Wu H
    Free Radic Biol Med; 2017 Jul; 108():840-857. PubMed ID: 28457936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fortunellin protects against high fructose-induced diabetic heart injury in mice by suppressing inflammation and oxidative stress via AMPK/Nrf-2 pathway regulation.
    Zhao C; Zhang Y; Liu H; Li P; Zhang H; Cheng G
    Biochem Biophys Res Commun; 2017 Aug; 490(2):552-559. PubMed ID: 28624452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
    Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
    Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-O-methylhonokiol protects against diabetic cardiomyopathy in type 2 diabetic mice by activation of AMPK-mediated cardiac lipid metabolism improvement.
    Zheng Z; Ma T; Guo H; Kim KS; Kim KT; Bi L; Zhang Z; Cai L
    J Cell Mol Med; 2019 Aug; 23(8):5771-5781. PubMed ID: 31199069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azilsartan ameliorates ventricular hypertrophy in rats suffering from pressure overload-induced cardiac hypertrophy by activating the Keap1-Nrf2 signalling pathway.
    Hou N; Li LR; Shi YY; Yuan WC; Zhao GJ; Liu XW; Cai SA; Huang Y; Zhan HX; Pan WB; Luo CF
    J Pharm Pharmacol; 2021 Dec; 73(12):1715-1725. PubMed ID: 34343333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.